J Korean Med Assoc.
2021 Aug;64(8):543-550. 10.5124/jkma.2021.64.8.543.
Diagnosis and treatment of Charcot arthropathy in diabetic patients
- Affiliations
-
- 1Department of Orthopedic Surgery, Daejeon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Daejeon, Korea
- KMID: 2519078
- DOI: http://doi.org/10.5124/jkma.2021.64.8.543
Abstract
- Background
Charcot joint or neurogenic arthropathy in diabetes is a late complication invading the foot and ankle that results in dislocation, instability, and deformity of the affected area. Sensory neuropathy leads to numbness and malalignment of the foot and ankle or inadequate post-traumatic response, which results in progressive fractures, multiple joint dislocations, ulcerations, osteomyelitis, and amputation. Because of such serious consequences, understanding of pathophysiology is important in determining treatment strategies. Early diagnosis and appropriate treatment can prevent this destructive process.
Current Concepts
The number of adults diabetic patients continuously increases. Health care and life expectancy will continue to improve with the development of medicine. As a result, the incidence of diabetes-related complications will increase. Diabetic Charcot joint will have a serious negative impact on the quality of life and financial burden on the diabetic patients. The goal of treatment for Charcot joint is not to build a normal foot, but to make a stable plantigrade foot that can be worn shoes. Therefore, it would be most important to understand the progress and characteristics of the disease and to develop an appropriate plan in order to select the appropriate treatment method.
Discussion and Conclusion
Understanding Charcot joint and familiarization with its appropriate treatment should reduce the number of the cases of diabetic Charcot joint patients with disabilities or amputations.
